Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annika Herlemann

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
European Urology|November 8, 2019
Pretreatment Risk Stratification Tools for Prostate Cancer-Moving from Good to Better, Toward the BestAnnika Herlemann
BJU International|April 23, 2019
Editorial: Conversion to negative surgical margin after intraoperative frozen section - (un)necessary effort and relevance in 2019?Annika Herlemann, Maxwell V Meng
Der Urologe. Ausg. A|February 3, 2016
[Active surveillance for low-risk prostate cancer]Annika Herlemann, Christian G Stief
European Urology Focus|December 28, 2018
Health Care Delivery for Metastatic Hormone-sensitive Prostate Cancer Across the GlobeAnnika Herlemann, Samuel L Washington, Matthew R Cooperberg
MMW Fortschritte Der Medizin|September 7, 2013
[Management of benign prostate syndrome]Annika Herlemann, Frank Strittmatter, Christian G Stief, et al.
Current Opinion in Urology|February 22, 2017
Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and stagingRenu S Eapen, Annika Herlemann, Samuel L Washington, et al.
The Urologic Clinics of North America|November 7, 2017
Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic ClassifierAnnika Herlemann, Samuel L Washington, Renu S Eapen, et al.
European Urology|May 14, 2017
Community-based Outcomes of Open versus Robot-assisted Radical ProstatectomyAnnika Herlemann, Janet E Cowan, Peter R Carroll, et al.
MMW Fortschritte Der Medizin|April 12, 2021
[Prostate cancer: When to treat, which treatment options by stage?]Benedikt Ebner, Michael Chaloupka, Elena Berg, et al.
MMW Fortschritte Der Medizin|April 12, 2021
[Prostate cancer: Screening, imaging, targeted diagnostics]Elena Berg, Benedikt Ebner, Annika Herlemann, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
European Urology|November 8, 2019
Pretreatment Risk Stratification Tools for Prostate Cancer-Moving from Good to Better, Toward the BestAnnika Herlemann
BJU International|April 23, 2019
Editorial: Conversion to negative surgical margin after intraoperative frozen section - (un)necessary effort and relevance in 2019?Annika Herlemann, Maxwell V Meng
Der Urologe. Ausg. A|February 3, 2016
[Active surveillance for low-risk prostate cancer]Annika Herlemann, Christian G Stief
European Urology Focus|December 28, 2018
Health Care Delivery for Metastatic Hormone-sensitive Prostate Cancer Across the GlobeAnnika Herlemann, Samuel L Washington, Matthew R Cooperberg
MMW Fortschritte Der Medizin|September 7, 2013
[Management of benign prostate syndrome]Annika Herlemann, Frank Strittmatter, Christian G Stief, et al.
Current Opinion in Urology|February 22, 2017
Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and stagingRenu S Eapen, Annika Herlemann, Samuel L Washington, et al.
The Urologic Clinics of North America|November 7, 2017
Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic ClassifierAnnika Herlemann, Samuel L Washington, Renu S Eapen, et al.
European Urology|May 14, 2017
Community-based Outcomes of Open versus Robot-assisted Radical ProstatectomyAnnika Herlemann, Janet E Cowan, Peter R Carroll, et al.
MMW Fortschritte Der Medizin|April 12, 2021
[Prostate cancer: When to treat, which treatment options by stage?]Benedikt Ebner, Michael Chaloupka, Elena Berg, et al.
MMW Fortschritte Der Medizin|April 12, 2021
[Prostate cancer: Screening, imaging, targeted diagnostics]Elena Berg, Benedikt Ebner, Annika Herlemann, et al.
Pageof 7